Metals in Medicine 2017
DOI: 10.1002/9781119191377.ch4
|View full text |Cite
|
Sign up to set email alerts
|

Anticancer Agents Beyond Cisplatin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 198 publications
0
1
0
Order By: Relevance
“…However, researchers still try to overcome the problem of side effects arising with platinum compounds. There is continuous focus on the development of alternatives to platinum compounds with more specific actions. , In the context of photo dynamic therapy (PDT), ruthenium­(II) complexes were found to be interesting thanks to their large Stoke’s shift, absorption in the visible area, and ability to form singlet oxygen (type II photo-oxidation). , In addition to singlet oxygen photoproduction, some of these complexes have been shown to be highly oxidant under light irradiation . These properties have been used to trigger oxidative electron transfer with DNA (type I photo-oxidation).…”
Section: Introductionmentioning
confidence: 99%
“…However, researchers still try to overcome the problem of side effects arising with platinum compounds. There is continuous focus on the development of alternatives to platinum compounds with more specific actions. , In the context of photo dynamic therapy (PDT), ruthenium­(II) complexes were found to be interesting thanks to their large Stoke’s shift, absorption in the visible area, and ability to form singlet oxygen (type II photo-oxidation). , In addition to singlet oxygen photoproduction, some of these complexes have been shown to be highly oxidant under light irradiation . These properties have been used to trigger oxidative electron transfer with DNA (type I photo-oxidation).…”
Section: Introductionmentioning
confidence: 99%